PROM1 and glioblastoma: In fact, Calabrese et al. reported in 2007 that CD133+ and Nestin+ glioblastoma cells reside at the level of a tissutal vascular niche; the co-implantation in immunodeficient mice of both CD133+ tumor cells and endothelial cells improved the growth of tumor xenografts [315].